Journal of Pharmaceutical Policy and Practice

SJR Rank #7,682H-index: 40SJR: 0.740Best quartile: Q1Open AccessAPC: US$2,390Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)Q1
  • PharmacyQ1
  • Health PolicyQ2

Areas: Health Professions · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Pharmaceutical Economics and PolicyPharmaceutical Practices and Patient OutcomesAntibiotic Use and ResistancePharmaceutical Quality and CounterfeitingHealth Systems, Economic Evaluations, Quality of LifeMedication Adherence and CompliancePharmaceutical studies and practicesPharmacovigilance and Adverse Drug ReactionsVaccine Coverage and HesitancyHealthcare Systems and Reforms

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504080120160

Detailed Information

ISSN

2052-3211

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

2.56

References per Document

40.79

Coverage

2013-2026

Scope

Journal of Pharmaceutical Policy and Practice (formerly known as Southern Med Review) provides a platform for researchers to disseminate empirical research findings, with the aim that people everywhere have access to the medicines they need and use them rationally. The Journal encompasses all aspects of pharmacy including clinical, social, administrative or economic, and provides a platform to researchers, academics and practitioners from around the world to share new evidence, concerns and perspectives.

Metrics from SCImago Journal Rank 2025. View on SCImago